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Background  
Allergic contact dermatitis (ACD) is one of the most common skin diseases, affecting 15 
to 20% of the general population worldwide (1). It is classified as a delayed-type 
hypersensitivity response. Murine contact hypersensitivity (CHS) is a frequently used 
animal models of ACD (2). Recent evidences show that Foxp3+ regulatory T cells (Tregs) 
play essential roles in the regulation of various immune responses including CHS (3-5).  
   Helios, an Ikaros family transcription factor, is expressed at a high level in Tregs and 
has been suggested to play an important role in the suppressive function (6). It was 
proposed to be a good marker for thymus-derived Tregs (7). In addition, Helios augments 
transactivation of Foxp3 by binding directly to the Foxp3 promoter (6). Therefore, Helios 
is a potential modulator of Treg functions.  
   These notions led to increased interests in potential roles of Helios in inflammatory skin 
diseases, such as CHS. However, the function of Helios+ Tregs has yet to be determined, 
since both Foxp3 and Helios are intracellular markers and cannot be used for isolation of 
Tregs subsets.  
 
Questions addressed  
To solve these problems, we established a Helios reporter mouse strain that enabled us to 
analyze live Helios+ Tregs. Using this strain, we assessed the suppressive activity of 
Helios+ Tregs in skin draining lymph nodes (DLNs) responding to CHS.  
 
Experimental design  
  
Venus cDNA, encoding a variant of green fluorescent protein (GFP), was inserted 
downstream of the first ATG of Helios through a homologous recombination in the 
KY1.1 ES cell-line, which was established from F1 blastocysts derived by mating 
C57BL/6J and 129S6/SvEvTac (Fig. 1a) (8).  
Results  
The expression of Foxp3 and Helios of CD4+ T cells were differentiated in various tissues 
of HeliosVenus/Foxp3hCD2/hCD52 reporter mice. In the thymus, most of the Foxp3+ cells were 
Helios+. In contrast, the expression level of Helios varied in the peripheral lymphoid 
organs, such as the spleen and the mesenteric lymph nodes (mLNs) (Fig. 1b). Nearly all 
Foxp3+ Tregs in the thymus expressed Helios, whereas around 60 % of Foxp3+ Tregs 
expressed Helios in the spleen and the mLN (Fig. 1c). These observations were consistent 
with those by Thornton et al. (7). We also determined the absolute number of Helios+ 
Tregs (Fig. 1d). Intriguingly, Helios+ Tregs showed a relative increase in CD25 
expression as well as CTLA-4 compared to Helios- Tregs (Fig. 1e and f). These data 
imply that Helios+ Tregs may possess higher suppressor activity than Helios- Tregs. 
   We focused on the DLNs of ear skin and assessed the number of T cells that express 
Helios and/or Foxp3. We challenged the ear skin of C57BL/6 mice with 
2,4-dinitro-1-fluorobenzene (DNFB) and collected the DLNs between day 0 and 7 after 
the challenge. The number of both Helios+ and Helios- subsets was increased in the DLNs 
after the challenge (Fig. S1). There was a tendency that the number of Helios+ Tregs was 
dominated over that of the Helios- subset during the CHS.  
  
   Next, we investigated whether Helios expression correlated with the suppressive 
function of Tregs residing in the DLNs during CHS. We sorted Tregs into Helios+ and 
Helios- fractions using FACSAria II (Fig. 2a). We assessed the suppressive activity of the 
sorted fractions by culturing them with regional LN cells of DNFB-sensitized mice, 
which contained antigen-specific non-Tregs as well. T cells in the regional LNs 
proliferated in response to 2,4-dinitrobenzene sulfonic acid (DNBS), a water-soluble 
compound with the same antigenicity as DNFB. Addition of Tregs inhibited the 
proliferation of DNBS-responding T cells in a dose dependent manner (Fig. 2b, left). 
Helios+ Tregs suppressed the T cell-proliferation at fewer numbers than Helios- Tregs did, 
indicating that antigen- or hapten-specific Tregs were enriched in the Helios+ population 
(Fig. 2b, left). Furthermore, superiority of suppressive function of Helios+ Tregs over 
Helios- counterpart was observed for T cell proliferation mediated by plate-bound 
anti-CD3ϵ (Fig. 2b, right). This result indicates that Helios+ Treg-population is poised to 
inhibit immune response and is enriched with antigen-specific clones.  
   Since IFN-γ and IL-17 are known to be involved in the effector phase of CHS and to 
lead to recruitment of T cells in the skin (S2-4), we measured these cytokines in 
supernatants. We found that Helios+ Tregs inhibited the production of inflammatory 
cytokines by LN cells more efficiently than Helios- Tregs did (Fig. 2c). The significance 
of suppression was comparable between Helios+ and Helios- Tregs when T cells were 
stimulated with DNBS, whereas Helios+ Tregs showed superiority for suppressing T cells 
stimulated by plate-bound anti-CD3ϵ (Fig. 2c, upper graphs). In contrast, Helios+ Tregs 
showed superior suppression on IL-17-production mediated by both DNBS and 
  
plate-bound anti-CD3ϵ (Fig. 2c, lower graphs). Our findings suggest that Helios+ Tregs 
preferably inhibit IL-17 production rather than IFN-γ production. Recent study showed 
that TIGIT+ Tregs are highly suppressive and selectively suppress Th1 and Th17 cells but 
not Th2 cell responses (S5). Likewise, Helios+ Tregs may be endowed with a function 
that suppress production of certain cytokines including IL-17.  
   In our study, Helios+ Tregs inhibited the production of inflammatory cytokines such as 
IFN-γ and IL-17 more efficiently than Helios- Tregs did. Some investigators reported that 
heat shock protein 70 (HSP70), which is one of the inflammatory mediators of CHS, 
attenuates CHS by increasing TGF-β secretion and number of CD4+CD25+Foxp3+ Tregs 
(9). As Helios is effectively induced with TCR-stimulation in the presence of TGF-β (7), 
these findings have important implications for therapeutic strategy to attenuate CHS by 
deliberately increasing Helios+ Tregs in the skin DLNs with HSP70. 
 
Conclusions  
We generated HeliosVenus mice, a strain that enables us to isolate Helios+ cells. Using this 
system, we could assess the suppressive function of Helios+ Tregs. Our finding indicated 
that Helios is a new marker for isolating or preparing potent suppressive Tregs.  
   HeliosVenus mice can be applied to analyze the function and developmental process of 
Helios+ cells, which include Foxp3+ Tregs, Helios+ conventional T cells of unknown 
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(a) Targeting of murine Helios gene. A targeting vector named p88C8, containing Venus 
cDNA with a terminator sequence (white box) and a neomycin-resistant gene (NeoR) 
cassette flanked with FLP recombinase targets (FRT), was introduced in KY1.1 ES cells 
by electroporation followed by selection by G418. We analyzed the clones by genomic 
Southern blots and found five independent clones, three of which were used for blastocyst 
injections. Numbered boxes indicate exons. ATG indicates the first start codon residing in 
exon 2. FRT indicates flippase recognition target. (b) Expression of Helios in Tregs in 
  
various tissues. CD4+ T cells in HeliosVenus/Foxp3hCD2/hCD52 mice were assessed for the 
expression of Helios. Representative flow plots, gated on CD4+ T cells, show the 
frequency of cells expressing Foxp3 and Helios. In the thymus, most of the Foxp3+ cells 
were Helios+. CD4SP and LNs indicates CD4 single positive thymocytes and lymph 
nodes, respectively. (c and d) The percentage and number of Foxp3+CD4 T cells 
expressing Helios. (e) Mean fluorescence intensity (MFI) of CD25 and (f) CTLA-4. 
Statistical significance between the indicated groups was indicated by * and **** for P 
<0.05 and P <0.0001, respectively. 
 
Figure 2. 
(a) The skin DLNs of HeliosVenus/Foxp3hCD2/hCD52 mice were collected five days after 
sensitization with DNFB and were stained with CD4 and hCD2 mAbs. The flow 
cytometric plot shows Helios and hCD2/Foxp3 expression among CD4+ cells. 
(b) Skin DLN cells of mice sensitized with DNFB were stimulated with DNBS or 
anti-CD3ϵ Ab in the presence or absence of Helios-Tregs or Helios+ Tregs in vitro.  
Asterisk (*) indicates P <0.05 between the indicated groups. Data are presented as means 
± SEM. 
(c) Suppressive effect of Helios+ Tregs on cytokine production in vitro. Skin DLN cells 
were stimulated as above and cultured for 72 hours and then supernatants were prepared 
for cytokine production. Asterisk (*) indicates P <0.05 between the indicated groups. 
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E-supplement 
Experimental design  
Targeted KY1.1 clones were injected in Blastocysts, obtained from F1 of C57BL/6CrSlc 
females and DBA/2CrSlc males, were injected with Helios-targeted KY1.1 clones and 
transferred into pseudopregnant ICR female mice to obtain chimaera mice, which were 
mated with C57BL/6J to generate HeliosVenus reporter mouse strain that expresses Venus 
under the control of Helios promoter. The strain was backcrossed to C57BL/6 mice for at 
least 8 generations. 
   To evaluate the role of Helios+ Tregs, we generated HeliosVenus/Foxp3hCD2/hCD52 mice by 
inter-crossing HeliosVenus mice with Foxp3hCD2/hCD52, in which Foxp3+ Tregs express 
human CD2/human CD52 fusion protein on the surface (S1). These mice were bred in 
specific pathogen-free facilities at Kyoto University. All experimental procedures were 
approved by the Institutional Animal Care and Use Committee of Kyoto University 
Faculty of Medicine. Fluorochrome-conjugated anti-mouse CD3ϵ, CD4, CD8a, CD25, 
CD45.2, 7-AAD, Helios, Foxp3, human CD2, CTLA-4 and Helios mAbs were obtained 
from BD Bioscience (San Jose, CA), eBiosciences (San Diego, CA), or Biolegend (San 
  
Diego, CA). Data were acquired using LSRFortessa (BD Biosciences) and analyzed with 
FlowJo software (TreeStar, San Carlos, CA). For cell-sorting, Helios+ Tregs or Helios- 
Tregs were purified from inguinal and axillary lymph nodes (LNs) of 
HeliosVenus/Foxp3hCD2/hCD52 mice by the FACSAria II flow cytometry system (BD 
Biosciences). For 2,4-dinitrobenzene sulfonic acid (DNBS)-dependent cell proliferation, 
mice were sensitized with 50 μl of 0.5% (wt/vol) 2,4-dinitro-1-fluorobenzene (DNFB) 
(Nacalai Tesque, Kyoto, Japan) in acetone/olive oil (4:1) on the dorsal skin. Five days 
later, single-cell suspensions were prepared from inguinal and axillary LNs and were 
cultured in 96-well plate at densities of 7 × 105 LN cells/well in RPMI 1640 containing 
10% fetal bovine serum (FBS) with or without 50 μg/ml DNBS for 72 hours. IFN-γ and 
IL-17 in the culture supernatants were measured by ELISA (R&D systems, Minneapolis, 
MN). Otherwise plate-bound anti-CD3ϵ antibody (immobilized at 1µg/ml in PBS without 




Kinetics of Helios+ or Helios- Tregs in the DLNs after the DNFB challenge. The number 
of Helios+ Tregs in the DLNs was much higher than Helios- Tregs at each time point 
tested. Asterisk (*) indicates P <0.05 between the indicated groups. Data are presented as 
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